MAPT and Alzheimer disease: Apart from a positive correlation between the hippocampal expression of BDNF and Syt-1, BDNF abundance was found to be negatively correlated with markers of glial activation and the expression of the inflammatory cytokines, Aβ, and p-Tau, which are characteristic neuropathological features of AD.